ArticlePloS one2022

Sodium-glucose cotransporter 2 (SGLT2) inhibitor initiation and hepatocellular carcinoma prognosis.

Michael Hendryx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.